← Evidence map

ArticleTranslational andrology and urology2025

Patient-centered outcomes and preference between darolutamide and enzalutamide: insights from the ODENZA trial.

Guillaume Lim Fat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40529039